In this webinar, Dr Robert Williams, Chief Development Scientist, Cancer Research UK, will discuss how partnership between academia and industry can accelerate drug development. He will also cover business models that are being implemented to progress the drug pipeline and resurrect deprioritised candidates. Finally, Robert will provide an update on the ongoing collaboration between Medimmune and Cancer Research UK.
Driving Innovation in Antibody Discovery and Development Through Novel Partnership Models
Video Aug 23, 2016
A Mass. General Hospital study reveals how solid stress from nodular brain tumors compresses adjacent healthy tissue, restricts blood supply and damages neurons. The psychiatric drug lithium may be able to reduce these effects. (Giorgio Seano, PhD, Steele Laboratories of Tumor Biology, Department of Radiation Oncology, Massachusetts General Hospital)